Colon cancer vaccine - Antigen Express

Drug Profile

Colon cancer vaccine - Antigen Express

Latest Information Update: 27 Aug 2008

Price : $50

At a glance

  • Originator Antigen Express
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Colorectal cancer

Most Recent Events

  • 27 Aug 2008 Discontinued - Preclinical for Colorectal cancer in USA (unspecified route)
  • 14 Apr 2005 Preclinical trials in Colorectal cancer in USA (unspecified route)
  • 15 Aug 2003 Antigen Express has been acquired by Generex Biotechnology Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top